Yahoo Finance

Guerbet announces the acquisition of a new microsphere technology to strengthen its interventional imaging range

Acquisition of a technology developed by Occlugel, a French company specialized in the R&D of microspheres used in embolization; This new technology will round out Guerbet`s Interventional Imaging ...
Yahoo Finance

Read This Before You Buy Guerbet SA (EPA:GBT) Because Of Its P/E Ratio

How Do You Calculate A P/E Ratio? The formula for price to earnings is: Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS) Or for Guerbet: P/E of 13.62 = €47.00 ÷ €3.45 (Based on the ...
PharmiWeb

Guerbet To Showcase the New Dose&Care® and other Digital Solutions with Diagnostic and Interventional Imaging Offerings at RSNA 2019

PRINCETON, N.J., Nov. 25, 2019 /PRNewswire/ -- Guerbet LLC USA, the U.S. affiliate of the global specialist in contrast media products and comprehensive solutions for medical imaging, will highlight ...
Business Insider

GUERBET : Guerbet announces its acquisition of Accurate Medical Therapeutics, an innovative company that develops microcatheters for interventional radiology

Villepinte (France), January 8, 2018 (17:45 CET) - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announced that it has entered into an agreement ...
Yahoo Finance

Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects

Villepinte, November 3rd, 2022: Guerbet today announced an agreement with Merative, formalizing the termination of their collaboration signed in July 2018. Guerbet today announced an agreement with ...
manilatimes

Guerbet: Appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee

François Convenant joined GUERBET in September 2018. He has extensive international experience in the healthcare and medical device sector. Before joining Guerbet, he held management positions at ...
Yahoo Finance

Guerbet strengthens its Executive Committee with the appointment of Charlotte Bamière, General Counsel

with the appointment of Charlotte Bamière, General Counsel Villepinte, April 6, 2022 – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and medical imaging solutions, has announced ...
TCTMD

Guerbet receives FDA 510k clearance for the OptiOne™ Single-Head Contrast Delivery System

PRINCETON, N.J., Guerbet announced that it has received 510K clearance from the US Food and Drug Agency (FDA) for its OptiOne™ Single-Head Contrast Delivery System, featuring advanced multi-purpose ...
manilatimes

Guerbet: Karim Boussebaa appointed Chief Executive Officer

Villepinte, January 28, 2026: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces the appointment of Mr. Karim Boussebaa as Chief Executive ...
Mena FN

Guerbet Announces Commercial Launch And First Patient Dosing Of Eluciremtm (Gadopiclenol) Injection, A Novel New Macrocyclic GBCA For Use In Contrast-Enhanced Magnetic ...

EluciremTM has the highest relaxivity compared to other non-specific GBCAs (gadolinium-based contrast agents) 1 EluciremTM requires only half the gadolinium dose of conventional non-specific GBCAs, ...
PR Newswire

Guerbet, a New Global Leader En Route to the Future

Guerbet(FR0000032526 GBT), the global specialist in contrast agents and solutions for medical imaging, today celebrates its 90th year with all its 2,600 employees and ...
Finanznachrichten

GUERBET: Adjustment of 2025 financial targets

Villepinte, 2 December 2025, 5.45 p.m.- Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward revision to its financial targets ...